West Pharmaceutical Services, Inc. (WST) Tops Q1 EPS by 1c; Guides In-Line
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $371.62 +0.14%
EPS Growth %: +11.7%
Financial Fact:
Gross profit: 121.1M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: +11.7%
Financial Fact:
Gross profit: 121.1M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
West Pharmaceutical Services, Inc. (NYSE: WST) reported Q1 EPS of $0.87, $0.01 better than the analyst estimate of $0.86. Revenue for the quarter came in at $339.4 million versus the consensus estimate of $344.2 million.
West Pharmaceutical Services, Inc. sees FY2013 EPS of $3.05-3.20, versus the consensus of $3.13.
For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.
West Pharmaceutical Services, Inc. sees FY2013 EPS of $3.05-3.20, versus the consensus of $3.13.
For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- Cintas Corp. (CTAS) Tops Q1 EPS by 1c, Offers Guidance
- UBS Reiterates Buy Rating on KB Home (KBH) Amid Transition Back to Built-to-Order
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
